Firefly Neuroscience, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Firefly Neuroscience, Inc. now
Current reporting with the operating signal separated from the noise.
Firefly Neuroscience, Inc. Collaborates with Heidelberg University Hospital on EEG Study of 15q13.3 CNVs to Advance Precision Neuroscience
The story matters when it changes Firefly Neuroscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Is Firefly Neuroscience, Inc. (AIFF) The Best Day Trading Stock To Invest In Now?
Investors are testing whether Firefly Neuroscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Why Firefly Neuroscience, Inc. (AIFF) Is Soaring This Year So Far
The development tests whether Firefly Neuroscience, Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Latest AIFF filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Firefly Neuroscience, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →